VCEL NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Vericel Corp Ord · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 45.09 USD
-1.9% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 19.7% above the Trend Line and sits at 79.2% of its 52-week range. The latest completed week returned -1.9%, after a -4.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 56/100 conviction, while the latest news-sentiment score is 61/100. Near-term considerations: volume confirmation is below normal.

Setup score 53 out of 100
Latest Close 45.09 USD 7 Aug 2026
1W Return -1.9% latest completed week
4W Return -4.1% short-term follow-through
12W Return 36.5% quarterly tape
Trend Breadth 25.0% 13 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 7-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.9% Latest completed week; four-week move -4.1%. Indicator stack 38/66 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 56/100 conviction; expected move 8.3%. News sentiment 61/100 54 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 19.7% above the Trend Line and sits at 79.2% of its 52-week range. The latest completed week returned -1.9%, after a -4.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7212-week average 0.32

12-week confirmation

Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.72Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.1% over four weeks, 36.5% over 12 weeks, and 24.4% over one year. The current trend has remained active for 7 consecutive weeks.

Performance by holding period

1W-1.9%
4W-4.1%
12W36.5%
26W24.6%
52W24.4%
Active trend streak7 weeks
Active weeks in one year13
Trend breadth25.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.03Latest activity-pressure read.
Pressure change-36.9%Four-week change in activity pressure.
Leadership7.16Latest relative-leadership reading.
RS change-36.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Jun 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength16/100Blend of value, momentum, and quality. Underlying universe rank 85; rank 1 is best.
Value3/100Relative valuation strength. Underlying universe rank 98; rank 1 is best.
Quality89/100Profitability and accounting quality. Underlying universe rank 12; rank 1 is best.
Momentum34/100Medium-term price momentum. Underlying universe rank 67; rank 1 is best.
Growth100/100Revenue and earnings growth. Underlying universe rank 1; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework4/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
95.3x
Price divided by trailing earnings.
Price / sales
7.5x
Market value relative to trailing revenue.
EV / EBITDA
59.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
74.6%
Gross profit retained from each unit of revenue.
Operating margin
8.4%
Operating profit retained from revenue.
Free-cash-flow margin
29.3%
Free cash flow generated from revenue.
Return on invested capital
7.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
23.0%
Latest one-year revenue growth.
EPS growth
240.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-25.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.3%
Net share repurchases relative to market value.
Shareholder yield
-0.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

VCEL shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.04, expected move of 8.3%, and Sharemaestro trend signal active.

Conviction56/100
Expected move8.3%
Put/call volume0.04
Pressure100
Speculation25
Volatility89
Trend agreement0
Open options detail
Insider activity11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment61/100

Weighted news tone is neutral across 54 relevant articles.

21 positive · 31 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move8.3%Nearest-chain priced movement where available.
52-week drawdown-8.6%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+16.4%Week of 3 Apr.
Worst week-6.6%Week of 27 Mar.
Latest week-1.9%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains4
Flat weeks0
Modest losses10
Sharp losses5
Recent vol5.3%13-week weekly-return volatility.
Base vol5.6%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew5.2% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape50/100

Trend, activity pressure, participation, and risk combine to a 50/100 tape read.

 Indicator analysis68/100

Latest 12-week confirmation: trend 7/12, activity pressure 12/12, relative leadership 7/12.

Activity pressure 0.72; No reversal markers Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 74; Small Cap Core rank 99 SVQF4/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 691.5 of 718 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options37/100

VCEL shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.04, expected move of 8.3%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 8.3% Sentiment61/100

Weighted news tone is neutral across 54 relevant articles.

Vericel Q2 Earnings Call Highlights Insiders11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202645.09 USD-1.9%37.67 USD41.87 USD1.037.162.2MOn
31 Jul 202645.96 USD2.0%37.46 USD41.78 USD1.2314.762.8MOn
24 Jul 202645.05 USD-3.4%37.11 USD41.69 USD1.3713.192.6MOn
17 Jul 202646.64 USD-0.8%36.87 USD41.65 USD1.5915.112.3MOn
10 Jul 202647.00 USD0.0%36.51 USD41.60 USD1.6411.322.5MOn
3 Jul 202646.98 USD1.6%36.16 USD41.54 USD1.5113.012.8MOn
26 Jun 202646.23 USD15.3%35.81 USD41.47 USD1.3111.814.7MOn
19 Jun 202640.10 USD7.0%35.61 USD41.42 USD0.74-7.713.6MOff
12 Jun 202637.46 USD3.2%35.59 USD41.39 USD0.47-12.232.5MOff
5 Jun 202636.30 USD8.9%35.67 USD41.37 USD0.20-13.803.3MOff
29 May 202633.33 USD-4.0%35.76 USD41.36 USD0.08-25.161.8MOff
22 May 202634.73 USD5.1%35.81 USD41.36 USD0.24-20.633.2MOff
15 May 202633.03 USD-1.3%35.87 USD41.35 USD0.18-24.372.9MOff
8 May 202633.46 USD-5.9%35.94 USD41.35 USD0.16-24.464.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context